EP Wealth Advisors LLC Purchases 726 Shares of Colgate-Palmolive (NYSE:CL)

EP Wealth Advisors LLC grew its position in shares of Colgate-Palmolive (NYSE:CL) by 1.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 43,863 shares of the company’s stock after buying an additional 726 shares during the period. EP Wealth Advisors LLC’s holdings in Colgate-Palmolive were worth $4,256,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. E Fund Management Hong Kong Co. Ltd. bought a new position in Colgate-Palmolive during the second quarter worth about $25,000. Core Wealth Advisors Inc. raised its holdings in Colgate-Palmolive by 56.6% during the 4th quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock valued at $32,000 after acquiring an additional 146 shares during the period. Rise Advisors LLC purchased a new stake in shares of Colgate-Palmolive during the first quarter worth $38,000. Continuum Advisory LLC boosted its holdings in shares of Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after acquiring an additional 125 shares during the period. Finally, Voisard Asset Management Group Inc. purchased a new position in shares of Colgate-Palmolive in the fourth quarter valued at $40,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $103.80 on Tuesday. The business has a 50 day moving average price of $103.37 and a 200-day moving average price of $96.53. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06. The firm has a market cap of $85.16 billion, a PE ratio of 32.85, a price-to-earnings-growth ratio of 3.62 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The firm had revenue of $5.06 billion for the quarter, compared to the consensus estimate of $5 billion. During the same quarter in the prior year, the business earned $0.77 EPS. The business’s revenue for the quarter was up 4.9% on a year-over-year basis. Equities research analysts predict that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.93%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is presently 63.29%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, EVP Gregory Malcolm sold 10,533 shares of the company’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total value of $1,085,952.30. Following the sale, the executive vice president now owns 10,377 shares in the company, valued at $1,069,868.70. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Gregory Malcolm sold 10,533 shares of the company’s stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the completion of the transaction, the executive vice president now owns 10,377 shares in the company, valued at approximately $1,069,868.70. The disclosure for this sale can be found here. Insiders sold a total of 43,490 shares of company stock valued at $4,486,063 in the last three months. Company insiders own 0.34% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have commented on CL. Evercore ISI raised their target price on Colgate-Palmolive from $100.00 to $106.00 and gave the stock an “outperform” rating in a research note on Thursday, July 18th. Wells Fargo & Company cut shares of Colgate-Palmolive from an “equal weight” rating to an “underweight” rating and set a $100.00 price objective for the company. in a research note on Monday, September 16th. Stifel Nicolaus boosted their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Monday, July 22nd. Hsbc Global Res downgraded Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 26th. Finally, Piper Sandler assumed coverage on Colgate-Palmolive in a research note on Tuesday, September 24th. They set an “overweight” rating and a $121.00 price objective for the company. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus target price of $104.74.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.